Danaher (DHR) is a publicly traded Healthcare sector company. As of October 3, 2026, DHR trades at $214.07 with a market cap of $148.86B and a P/E ratio of 41.51. DHR moved +1.09% today. Year to date, DHR is -7.09%; over the trailing twelve months it is +1.77%. Its 52-week range spans $160.93 to $242.80. Analyst consensus is strong buy with an average price target of $223.11. Rallies surfaces DHR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Danaher files Form 3 for SVP, Chief Strategy Officer Shashanka Muppaneni: Danaher filed a Form 3 for SVP and Chief Strategy Officer Shashanka Muppaneni, disclosing 5,901 common shares held directly.
| Metric | Value |
|---|---|
| Price | $214.07 |
| Market Cap | $148.86B |
| P/E Ratio | 41.51 |
| EPS | $5.19 |
| Dividend Yield | 0.40% |
| 52-Week High | $242.80 |
| 52-Week Low | $160.93 |
| Volume | 2.97M |
| Avg Volume | 0 |
| Revenue (TTM) | $24.78B |
| Net Income | $3.69B |
| Gross Margin | 58.94% |
19 analysts cover DHR: 0 strong buy, 17 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $223.11.